Skip to main content
Top

Current Heart Failure Reports

Issue 3/2017

Content (6 Articles)

Open Access Decompensated Heart Failure (P Banerjee, Section Editor)

Pharmacological and Non-pharmacological Treatment for Decompensated Heart Failure: What Is New?

Parin Shah, Pierpaolo Pellicori, Joseph Cuthbert, Andrew L. Clark

Self-Care and Health Outcomes (R. Gallagher and R. Clark, Section Editors)

Six-Minute Walk Test for Assessing Physical Functional Capacity in Chronic Heart Failure

Huiyun Du, Parichat Wonggom, Jintana Tongpeth, Robyn A. Clark

Open Access Experimental Therapeutics (L.S. Maier, Section Editor)

Regulation of Cardiomyocyte T-Tubular Structure: Opportunities for Therapy

Ornella Manfra, Michael Frisk, William E. Louch

Experimental Therapeutics (L Maier, Section Editor)

Inhibition of Late Sodium Current as an Innovative Antiarrhythmic Strategy

Philipp Bengel, Shakil Ahmad, Samuel Sossalla

Experimental Therapeutics (L S Maier, Section Editor)

Therapeutic Targeting of PDEs and PI3K in Heart Failure with Preserved Ejection Fraction (HFpEF)

Valentina Sala, Jean Piero Margaria, Alessandra Murabito, Fulvio Morello, Alessandra Ghigo, Emilio Hirsch

Management of Heart Failure (T Meyer, Section Editor)

Addressing the Heterogeneity of Heart Failure in Future Randomized Trials

Annamaria Iorio, Andrea Pozzi, Michele Senni

Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine